European Patent Bulletin 2012/36 - European Patent Office

(A61K) I.1(1)
(54) PHARMAZEUTISCHE ZUSAMMENSET-
ZUNG MIT EINER INDOLVERBINDUNG
PHARMACEUTICAL COMPOSITION
COMPRISING INDOLE COMPOUND
COMPOSITION PHARMACEUTIQUE
CONTENANT UN COMPOSÉ INDOLE
(71) LG Life Sciences Ltd, LG Gwanghwamun
Bldg. 92 Sinmunno 2-ga, Jongno-gu, Seoul
110-062, KR
(72) KIM, Soon Ha, Daejeon 305-380, KR
KIM, Hyoung Jin, Daejeon 305-380, KR
PARK, Heui Sul, Daejeon 305-380, KR
GU, Seon Yeong, Daejeon 305-380, KR
KWAK, Hyo Shin, Daejeon 305-380, KR
PARK, Du Hee, Daejeon 305-380, KR
KIM, Hyo Soo, Daejeon 305-380, KR
CHO, Hyun Jai, Daejeon 305-380, KR
KIM, Ji Hyun, Daejeon 305-380, KR
KIM, Ju Young, Daejeon 305-380, KR
PARK, Kwang Min, Daejeon 305-380, KR
(74) Nicolle, Frederick Joseph, Elkington and Fife
LLP Thavies Inn House 3-4 Holborn Circus,
GB-London EC1N 2HA, GB
A61K 31/404 → (51) A61K 31/55
A61K 31/415 → (51) A01N 43/50
A61K 31/415 → (51) C07D 231/38
A61K 31/416 → (51) C07D 231/14
A61K 31/416 → (51) C07D 401/04
A61K 31/4164 → (51) C07D 233/64
A61K 31/4178 → (51) C07D 233/64
A61K 31/42 → (51) C07D 231/14
A61K 31/42 → (51) C07D 261/20
A61K 31/421 → (51) C07D 263/20
A61K 31/4245 → (51) C07D 205/04
A61K 31/425 → (51) A01N 43/78
A61K 31/425 → (51) A61K 31/135
A61K 31/435 → (51) A61K 31/135
A61K 31/437 → (51) A61K 9/20
A61K 31/437 → (51) A61K 31/10
A61K 31/437 → (51) C07D 471/04
A61K 31/4375 → (51) C07D 219/10
A61K 31/4375 → (51) C07D 471/04
A61K 31/438 → (51) C07D 231/14
A61K 31/439 → (51) C07D 498/20
A61K 31/44 → (51) A01N 43/42
A61K 31/44 → (51) C07D 213/74
A61K 31/44 → (51) C07D 231/14
A61K 31/4402 → (51) A61K 31/135
A61K 31/4427 → (51) C07D 213/74
A61K 31/4439 → (51) C07D 403/12
A61K 31/444 → (51) A61K 31/135
Europäisches Patentblatt
European Patent Bulletin
Bulletin européen des brevets
A61K 31/444 → (51) C07D 205/04
A61K 31/445 → (51) C07D 211/28
A61K 31/45 → (51) C07D 211/28
A61K 31/4523 → (51) C07D 211/28
A61K 31/4523 → (51) C07D 231/14
A61K 31/46 → (51) C07D 401/12
A61K 31/4706 → (51) A61P 33/06
(51) A61K 31/4709 (11) 2 493 470 A1*
A61K 31/7056 A61K 38/21
A61P 31/14
(25) En (26) En
(21) 10773799.1 (22) 27.10.2010
(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR
GB GR HR HU IE IS IT LI LT LU LV MC MK
MT NL NO PL PT RO RS SE SI SK SM TR
(86) US 2010/054194 27.10.2010
(87) WO 2011/053617 2011/18 05.05.2011
(30) 30.10.2009 US 256516 P
(54) DOSIERPLÄNE FÜR EINE HCV-KOMBINA-
TIONSTHERAPIE AUS BI201335, INTER-
FERON ALPHA UND RIBAVIRIN
DOSAGE REGIMENS FOR HCV COMBI-
NATION THERAPY COMPRISING
BI201335, INTERFERON ALPHA AND
RIBAVIRIN
RÉGIMES POSOLOGIQUES POUR UNE
THÉRAPIE EN COMBINAISON CONTRE LE
VHC COMPRENANT BI201335, L'INTER-
FÉRON ALPHA ET LA RIBAVIRINE
(71) Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim, DE
(72) HAEFNER, Carla, 55216 Ingelheim am Rhein,
DE
STEINMANN, Gerhard, 55216 Ingelheim am
Rhein, DE
STERN, Jerry O., Ridgefield, Connecticut
06877-0368, US
YONG, Chan-Loi, Ridgefield, Connecticut
06877-0368, US
(74) Hammann, Heinz, et al, Boehringer Ingelheim
Pharma GmbH & Co. KG Binger
Strasse 173, 55216 Ingelheim am Rhein, DE
A61K 31/473 → (51) C07D 311/68
(51) A61K 31/485 (11) 2 493 471 A1*
A61K 31/7036 A61P 1/12
A61K 31/165 A61K 31/7048
A61P 25/16 A61K 31/166
A61P 1/08 A61P 25/28
A61K 31/496 A61P 1/10
(25) En (26) En
(21) 10825843.5 (22) 22.10.2010
(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR
GB GR HR HU IE IS IT LI LT LU LV MC MK
MT NL NO PL PT RO RS SE SI SK SM TR
(86) AU 2010/001410 22.10.2010
(87) WO 2011/050397 2011/18 05.05.2011
(30) 26.10.2009 AU 2009905229
(54) NEUE ENTERALE KOMBINATIONSTHERA-
PIE
NOVEL ENTERIC COMBINATION
THERAPY
NOUVELLE POLYTHÉRAPIE GASTRO-
RÉSISTANTE
(71) Borody, Thomas Julius, Level 1, 229 Great
North Road, Five Dock NSW 2046, AU
(72) Borody, Thomas Julius, Five Dock NSW
2046, AU
(74) Zwicker, Jörk, et al, Dr. Volker Vossius Patent-
und Rechtsanwaltskanzlei Geibelstrasse
6, 81679 München, DE
42
Anmeldungen
Applications
Demandes (36/2012) 05.09.2012
A61K 31/495 → (51) A61K 31/135
A61K 31/496 → (51) A61K 31/485
A61K 31/496 → (51) C07D 401/06
(51) A61K 31/497 (11) 2 493 472 A1*
(25) En (26) En
(21) 10827343.4 (22) 22.10.2010
(84) AL AT BE BG CH CY CZ DE DK EE ES FI FR
GB GR HR HU IE IS IT LI LT LU LV MC MK
MT NL NO PL PT RO RS SE SI SK SM TR
(86) US 2010/053678 22.10.2010
(87) WO 2011/053518 2011/18 05.05.2011
(30) 27.04.2010 US 328480 P
26.10.2009 US 254917 P
(54) VERFAHREN ZUR SYNTHESE UND REI-
NIGUNG VON HETEROARYLVERBINDUN-
GEN
METHODS OF SYNTHESIS AND PURIFI-
CATION OF HETEROARYL COMPOUNDS
PROCÉDÉS DE SYNTHÈSE ET DE PURIFI-
CATION DE COMPOSÉS HÉTÉROARYLES
(71) Signal Pharmaceuticals, LLC, 4550 Towne
Centre Court, San Diego, CA 92121, US
(72) HARRIS, Roy, L., San Diego, CA 92109, US
SAPIENZA, John, Chula Vista, CA 91913, US
SHEVLIN, Graziella, San Diego, CA 92129,
US
PAPA, Patrick, Carlsbad, CA 92008, US
LEE, Branden, Gingsee, San Diego, CA
92130, US
PACKARD, Garrick, San Diego, CA 92121,
US
ZHAO, Jingjing, San Diego, CA 92129, US
JOKIEL, Patrick, Anthony, Princeton, NJ
08540, US
MORTENSEN, Deborah, San Diego, CA
92117, US
RIGGS, Jennifer, Cardiff, CA 92007, US
GAMBOA, Juan, Antonio, New York, NY
10009, US
BEAUCHAMPS, Marie, Georges, Flanders, NJ
07836, US
KREILEIN, Matthew, Michael, Watchung, NJ
07069, US
KOTHARE, Mohit, Atul, Bridgewater, NJ
08807, US
PERRIN-NINKOVIC, Sophie, La Jolla, CA
92037, US
PYE, Philip, Scotch Plains, NJ 07076, US
LEONG, William, Wei-Hwa, Westfield, NJ
07090, US
ELSNER, Jan, San Diego, CA 92122, US
CHOUDHURY, Anusuya, Churchville, PA
18966, US
(74) Jones Day, Rechtsanwälte, Attorneys-at-Law
Patentanwälte Intellectual Property Prinzregentenstraße
11, 80538 München, DE
A61K 31/497 → (51) C07D 231/14
A61K 31/497 → (51) C07D 401/14
A61K 31/4985 → (51) C07D 471/04
A61K 31/5025 → (51) C07D 487/04
A61K 31/505 → (51) C07D 213/74
A61K 31/506 → (51) C07D 213/74
A61K 31/506 → (51) C07D 219/10
A61K 31/506 → (51) C07D 239/28
A61K 31/506 → (51) C07D 239/48
A61K 31/506 → (51) C07D 401/14